Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 338

1.

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.

George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R, Redner RL, Rice L, Schipperus MR.

Br J Haematol. 2009 Feb;144(3):409-15. doi: 10.1111/j.1365-2141.2008.07464.x. Epub 2008 Nov 11.

PMID:
19016720
[PubMed - indexed for MEDLINE]
2.

A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.

Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL.

Clin Ther. 2007 May;29(5):950-62.

PMID:
17697914
[PubMed - indexed for MEDLINE]
3.

Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.

Kuter DJ, Mathias SD, Rummel M, Mandanas R, Giagounidis AA, Wang X, Deuson RR.

Am J Hematol. 2012 May;87(5):558-61. doi: 10.1002/ajh.23163. Epub 2012 Mar 28.

PMID:
22460421
[PubMed - indexed for MEDLINE]
4.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.

Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2.

PMID:
18242413
[PubMed - indexed for MEDLINE]
5.

Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey.

Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J.

Curr Med Res Opin. 2008 Oct;24(10):2767-76. doi: 10.1185/03007990802377461 . Epub 2008 Aug 19.

PMID:
18715526
[PubMed - indexed for MEDLINE]
6.

Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences.

Mathias SD, Gao SK, Rutstein M, Snyder CF, Wu AW, Cella D.

Curr Med Res Opin. 2009 Feb;25(2):375-83. doi: 10.1185/03007990802634119 .

PMID:
19192982
[PubMed - indexed for MEDLINE]
7.

Romiplostim in chronic immune thrombocytopenic purpura.

Cersosimo RJ.

Clin Ther. 2009 Sep;31(9):1887-907. doi: 10.1016/j.clinthera.2009.09.013. Review.

PMID:
19843480
[PubMed - indexed for MEDLINE]
8.

Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP).

Sanz MA, Aledort L, Mathias SD, Wang X, Isitt JJ.

Value Health. 2011 Jan;14(1):90-6. doi: 10.1016/j.jval.2010.10.017.

PMID:
21211490
[PubMed - indexed for MEDLINE]
9.

Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).

Klaassen RJ, Mathias SD, Buchanan G, Bussel J, Deuson R, Young NL, Collier A, Bomgaars L, Blanchette V.

Pediatr Blood Cancer. 2012 Mar;58(3):395-8. doi: 10.1002/pbc.23312. Epub 2011 Sep 9.

PMID:
21910213
[PubMed - indexed for MEDLINE]
10.

Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpura.

Newland A.

Eur J Haematol Suppl. 2009 Mar;(71):20-5. doi: 10.1111/j.1600-0609.2008.01209.x. Review.

PMID:
19200304
[PubMed - indexed for MEDLINE]
11.

Romiplostim: a review of its use in immune thrombocytopenia.

Keating GM.

Drugs. 2012 Feb 12;72(3):415-35. doi: 10.2165/11208260-000000000-00000. Review.

PMID:
22316355
[PubMed - indexed for MEDLINE]
12.

Romiplostim management of immune thrombocytopenic purpura.

Ipema HJ, Jung MY, Lodolce AE.

Ann Pharmacother. 2009 May;43(5):914-9. doi: 10.1345/aph.1L643. Epub 2009 Apr 28. Review.

PMID:
19401474
[PubMed - indexed for MEDLINE]
13.

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.

Shirasugi Y, Ando K, Miyazaki K, Tomiyama Y, Okamoto S, Kurokawa M, Kirito K, Yonemura Y, Mori S, Usuki K, Iwato K, Hashino S, Wei H, Lizambri R.

Int J Hematol. 2011 Jul;94(1):71-80. doi: 10.1007/s12185-011-0886-8. Epub 2011 Jun 25.

PMID:
21706145
[PubMed - indexed for MEDLINE]
14.

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Jamali F, Lemery S, Ayalew K, Robottom S, Robie-Suh K, Rieves D, Pazdur R.

Oncology (Williston Park). 2009 Jul;23(8):704-9.

PMID:
19711585
[PubMed - indexed for MEDLINE]
Free Article
15.

Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.

Chouhan JD, Herrington JD.

Pharmacotherapy. 2010 Jul;30(7):666-83. doi: 10.1592/phco.30.7.666. Review.

PMID:
20575632
[PubMed - indexed for MEDLINE]
16.

Romiplostim.

Frampton JE, Lyseng-Williamson KA.

Drugs. 2009;69(3):307-17. doi: 10.2165/00003495-200969030-00006. Review.

PMID:
19275274
[PubMed - indexed for MEDLINE]
17.

A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation.

Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL.

Health Qual Life Outcomes. 2007 Feb 22;5:11.

PMID:
17316442
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.

Stasi R, Evangelista ML, Amadori S.

Drugs. 2008;68(7):901-12. Review.

PMID:
18457458
[PubMed - indexed for MEDLINE]
19.

A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura.

Shirasugi Y, Ando K, Hashino S, Nagasawa T, Kurata Y, Kishimoto Y, Iwato K, Ohtsu T, Berger DP.

Int J Hematol. 2009 Sep;90(2):157-65. doi: 10.1007/s12185-009-0361-y. Epub 2009 Jun 20.

PMID:
19543952
[PubMed - indexed for MEDLINE]
20.

Romiplostim: a novel thrombopoiesis-stimulating agent.

Perreault S, Burzynski J.

Am J Health Syst Pharm. 2009 May 1;66(9):817-24. doi: 10.2146/ajhp080524. Review.

PMID:
19386944
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk